We are live on ! Find out more
ZURAW

Zura Bio Limited Warrants

Delisted

ZURAW was delisted on the 27th of August, 2024.

13 hedge funds and large institutions have $493K invested in Zura Bio Limited Warrants in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% less funds holding

Funds holding: 1413 (-1)

20% less capital invested

Capital invested by funds: $619K → $493K (-$126K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 4

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
4
Closed
1
Calls
$217K
Puts
Net Calls
+$217K
Net Calls Change
-$148K

ZURAW Hedge Fund Activity: Q1 2024 in Review

13 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Zura Bio Limited Warrants (ZURAW) for Q1 2024, worth a combined $493K — down 20% from $619K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of ZURAW and 0 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 0 added.

The largest seller was Boothbay Fund Management, exiting entirely with an estimated $59.1K sold.

  • 13 institutional investors held Zura Bio Limited Warrants (ZURAW) as of Q1 2024, down from 14 in Q4 2023.
  • Funds reported $493K of Zura Bio Limited Warrants stock for Q1 2024, down 20% quarter-over-quarter.
  • 0 funds opened new Zura Bio Limited Warrants positions in Q1 2024 and 1 closed out, a net change of -1 holder.
  • The largest Zura Bio Limited Warrants seller in Q1 2024 was Boothbay Fund Management, an estimated $59.1K sold.

Based on aggregated 13F filings for Q1 2024.